🚀 Exciting News from Nagi Bioscience! 🚀 We’re thrilled to announce the kick off of our exclusive Priority Access Program, bringing revolutionary SydLab™ One platform to 5 leading academic labs for C. elegans research! 🌍 SydLab™ One, a pioneering lab-on-a-device solution for automated #Celegans research, is a first-of-its-kind platform designed to transform and advance biological research, #drugdiscovery, and #safetyassessment. The participating research groups, recognized for their leadership in the fields of #oncology, #neurodegenerative diseases, #aging, and #toxicology, will be the first academic groups to integrate SydLab™ One into their facilities. Through this program, they will gain access to the fully automated, end-to-end solution that incorporates cutting-edge microfluidics, robotics, optics, and AI algorithms, accelerating scientific discovery and improving research precision and reproducibility. The installations begun this month, providing access to the benchtop platform to support high-impact research projects. We are proud to launch this program with some of the world’s top institutions and support them in this exciting journey. Learn more about Nagi Bioscience' Priority Access Program and the SydLab™ One platform in our official press release here 👉🏼 https://lnkd.in/d8j5KnrW Stay tuned for further exciting updates about Nagi Bioscience's Priority Access Program! #inwormwetrust
Nagi Bioscience
Biotechnologieforschung
Lausanne, Vaud 3.250 Follower:innen
in vivo testing at the in vitro scale
Info
Nagi Bioscience is a pioneering high-tech startup developing NextGen laboratory equipment to unlock the full potential of alternatives to animal testing. Located in the heart of the Swiss "Health Valley”, we work for the transformation of biological testing standards providing cutting-edge equipment to achieve faster, scalable, more efficient and ethical methods. Under the motto “in vivo testing at the in vitro scale”, our technologies are accelerating drug development pipelines and introducing new toxicology testing standards revolutionizing pharmaceutical, cosmetic, and agro-chemical industries among others. Our approach? To unlock the full potential of small organisms, such as the well-characterized C. elegans nematode, for high-content screening of substances for safety and efficacy testing.
- Website
-
http://nagibio.ch/
Externer Link zu Nagi Bioscience
- Branche
- Biotechnologieforschung
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Lausanne, Vaud
- Art
- Privatunternehmen
- Gegründet
- 2019
Orte
-
Primär
EPFL
Lausanne, Vaud 1015, CH
Beschäftigte von Nagi Bioscience
-
Alain Lommelé
R&D Manager | Program Manager | Engineering & Business | Innovation | International
-
Regis Duval
Chief Commercial Officer | Breaking barriers & building innovative commercial strategies | Driving sustainable growth | Revolutionizing In Vitro…
-
Matteo Cornaglia
CEO and founder at Nagi Bioscience (nagibio.ch)
-
Katarzyna Wyrzykowska
Financial strategy, planning & controlling, fractional CFO for startups.
Updates
-
We are delighted to support Professor Wolf Reik's talk organized by Cambridge Society of Ageing and Longevity Research! 🌱 As researchers continue to uncover the complexities of #ageing, having access to the right tools and models is crucial for accelerating breakthroughs. At Nagi Bioscience, we’re committed to enabling scientists with cutting-edge technologies that provide deeper insights and help drive life-changing discoveries forward. Join us tomorrow and have a chat with our expert Alice Cheesbrough, who will be available to discuss how our innovative #lifespan and #healthspan assay on our SydLab™ One platform can accelerate your research 🚀 We look forward to connecting with you tomorrow! Do not miss this opportunity to learn more about the future of ageing research! #inwormwetrust
We are excited to announce that we will be hosting a presentation by Professor Wolf Reik, the Director of Altos Labs at Cambridge, titled "Single Cell Multi-Omics Landscape of Development and Ageing". 🌱 Professor Reik, a pioneering scientist in the field of epigenetics and ageing, will share his insights into how single-cell multi-omics technologies are revolutionising our understanding of developmental biology and the ageing process. Don’t miss this opportunity to learn from a leading expert - mark your calendars and stay tuned for more details! 📅
-
🚨 Poster Alert! Last week, we had the fantastic opportunity to participate in the #XAIB24 Conference! It was an incredible experience to present our poster on how we use ML-based image analysis and #AI to streamline #ageing studies in #Celegans by end-to-end automated high-throughput analysis. 🔬🤖 The Explainable AI in Biology Conference is dedicated to exploring the latest advancements in applying explainable and responsible AI techniques to genomics and biology, making it the perfect venue for discussing our work at Nagi Bioscience. Missed our presentation? Download the poster here 👉🏼 https://lnkd.in/e2bQ-rT2 Thank you to everyone who attended our presentation, and a big shoutout to the #XAIB24 organizing team The BioDev Network for such a well-organized and insightful event at Wellcome Sanger Institute! 🌱✨ #inwormwetrust #AIResearch #posterpresentation #labautomation #ML #biology #imageanalysis
-
🚀 Exciting News! We are thrilled to welcome Konstantinos Palikaras’ Lab from the Unit of Neurogenetics and Ageing, Laboratory of Physiology, at Ιατρική Σχολή ΕΚΠΑ/ NKUA Medical School to the SydLab™ One Priority Access Program! 🧠 Under the leadership of Professor Palikaras, their cutting-edge research focuses on understanding the molecular mechanisms behind age-related deterioration of the #nervoussystem, with a special focus on #mitochondrial quality control mechanisms. 🔬 Their project will harness the power of the SydLab™ One platform to screen 20 naturally occurring compounds for their effects on #longevity and #healthspan in #Celegans. Additionally, the lab will investigate the therapeutic potential of these compounds in #Alzheimer's disease nematode models, specifically those expressing beta-amyloid and Tau proteins. 💬 "Using the SydLab™ One platform, we will evaluate the mitophagy induction and neuroprotective capacities of these compounds, providing insights into their potential to ameliorate neurodegenerative symptoms associated with Alzheimer's disease." - Professor Konstantinos Palikaras, Group Leader. We are excited to support Palikaras’ Lab groundbreaking work and see what’s next on their journey of discovery and scientific innovation! 🚀 #inwormwetrust #neurodegenerativediseases #AD #drugdiscovery #screening #HT #ageing #labtechnology #SydLabOne #PriorityAccessProgram
-
🚀 Exciting news! A huge congratulations to Gary Ruvkun and Victor Ambros for being awarded the 2024 Nobel Prize in Physiology or Medicine for their groundbreaking discovery of #microRNA and its crucial role in gene regulation. This recognition marks yet another (the 4th!) #NobelPrize tied to a discovery made on #Celegans, reaffirming the incredible value of these tiny organisms in advancing human biology and transforming areas like #cancer research. At Nagi Bioscience, we're proud to lead the way in advancing C. elegans research by providing innovative technologies that enable scientists to generate the insights they need to fuel life-changing discoveries. Congratulations once again to the Nobel laureates! #inwormwetrust Check out the official press release below 👇🏼
Driving Innovation in Drug Discovery | Leveraging AI & Automation for Disruptive Solutions in Aging Science and Beyond | Co-Founder & CSO @ Nagi Bioscience | #Inwormwetrust
🚨 Breaking news! Huge congratulations to Gary Ruvkun and Victor Ambros for receiving the 2024 The Nobel Prize in Physiology or Medicine for their groundbreaking discovery of #microRNA and its pivotal role in gene regulation. When tiny #Celegans nematodes help uncover tiny #RNAs, the impact on human biology, especially #cancer research, is enourmous! This recognition highlights the incredible power of #Celegans as a model organism. At Nagi Bioscience, we’re proud to build on this legacy by delivering innovative solutions for automated and standardized #Celegans assays, fueling breakthroughs in #development, #aging, #neurodegeneration, and beyond. Today’s award reminds us of the immense potential that even the smallest organisms hold: Without a doubt, #inwormwetrust! Official Press Release here 👉🏼 https://lnkd.in/eKrxeSaF
-
Nagi Bioscience hat dies direkt geteilt
Proud to announce the most promising Swiss Biotech Startups and Scale-Ups of 2024, picked by a panel of 100 leading investors and industry experts. Read the full article: https://lnkd.in/dFD-CuCZ Discover the 15 Biotech Startups that impressed the TOP 100 Swiss Startup Award Jury in 2024: HAYA Therapeutics: Treating heart failure through innovative RNA-therapies. https://lnkd.in/dTqyuk_9 Araris Biotech AG: Building tomorrow's antibody-drug conjugates (ADCs). https://lnkd.in/dFRYX5g9 MUVON Therapeutics AG: Regain control with MUVON. https://lnkd.in/eaZrpZBU FimmCyte: First Disease Modifying Treatment for Endometriosis. https://lnkd.in/dYhuHXt4 Navignostics AG: Precision cancer treatment. https://lnkd.in/eH84t9q3 Noema Pharma: Beyond Symptom Control. https://lnkd.in/dAc5WdTR Recolony AG: Cancer immunotherapy inspired by symbiotic interactions. https://lnkd.in/egd_HKbV InkVivo Technologies AG: Best in class polymer platform for formulating drug delivery. https://lnkd.in/ey3ikTeF Perseo pharma AG: Next-Generation Enzyme Replacement Therapies. https://lnkd.in/dCwDGC_C GlycoEra AG: Glycobiology and protein degradation. https://lnkd.in/eMU3jRJa Limula: Cell and gene therapy made easy. https://lnkd.in/ecwJTvE4 Nagi Bioscience: “Organism-on-Chip” technology for drug/chemical screening. https://lnkd.in/ec4JkNG4 arcoscreen: We screen patients cells to improve drug discovery. https://lnkd.in/eepNRnZs Synendos Therapeutics AG: Therapies for neuropsychiatric disorders. https://lnkd.in/e4xdg6Av Tandem Therapeutics: Unlocking the matrix barrier in fibrotic diseases. https://lnkd.in/dacyKyqs About: The annual ranking of the TOP 100 Swiss Startups has become a benchmark in Switzerland’s startup ecosystem - and beyond. Every year, a panel of 100 leading investors and startup experts chooses the 100 most innovative and promising Swiss startups. Each jury member nominates 10 Swiss startups that are fewer than five years old and show the greatest commercial potential. They assign 10 points for the first place and one point for the tenth place. The companies with the most points make it into the TOP 100 Swiss Startup Ranking. #SwissStartups #BioTech #TOP100SSU
-
🚀 Join us at Ilmac Lausanne tomorrow! We will be showcasing our innovative SydLab™ One platform at our friends' booth BioAlps - Swiss Health Valley on September 18th-19th! Discover how our fully automated, AI-powered platform is revolutionizing lab automation and biological testing. Bonus! 📆 Don’t miss our CEO's Matteo Cornaglia’s pitch Thursday 19th at 1:30pm. Some interesting SydLab™ One use cases are waiting for you 😉 We can't wait to connect with you the next two days! #inwormwetrust Learn more here 👉🏼 https://lnkd.in/exfDRs57 #LifeSciences #LabAutomation #AI #Microfluidics #ILMAC2024 #DrugDiscovery #Toxicology #Celegans #MPS
-
🚀 Thrilled to be showcasing our Organism-on-Chip technology at #EUROTOX2024 in Copenhagen this week! We are proud to have our Northen Europe Territory Manager, Alice Cheesbrough, representing us at this leading event in toxicology, presenting our latest update on our novel approach for #DART studies. 👉🏼 Our poster showcases how the SydLab™ One platform is transforming the toxicology landscape, providing a high-throughput, integrated solution for early safety assessments in record time. 👉🏼 By streamlining the experimental process of #Celegans nematodes, we are pushing the boundaries of #toxicology and accelerating the pace of #drugdiscovery. Missed the poster session? Download it here 👉🏼 https://lnkd.in/egdUB6Nq #inwormwetrust #earlytox #NAMs #3Rs #MPS #labautomation EUROTOX Congress
-
We are proud to announce that we have been ranked again in the TOP100 Swiss Startups 2024 list! 🎉 This prestigious recognition highlights our ongoing efforts to revolutionize biological testing through faster, more efficient, and ethical solutions. A huge thank you to our incredible team, customers, partners, investors and supporters who have contributed to this achievement! We remain committed to unlocking the full potential of innovative biological models with our technologies and empowering scientists with the insights needed to accelerate life-changing discoveries. Congratulations to all the outstanding startups on the list and the top 3 winners! Here's to more success and innovation to come! 🚀 #inwormwetrust Read more about this exciting milestone here 👉 https://lnkd.in/eMNcZ9Ep #biotech #innovation #SwissStartups #TOP100SSU #lifesciences #biologicaltesting #startupsuccess #labautomation #labtechnologies #3Rs #NAMs
Nagi Bioscience ranked among the TOP100 Swiss Startups 2024 #inwormwetrust
https://nagibio.ch
-
🚨 Exciting news! In just a few hours, our CSO and co-founder Laurent Mouchiroud will take the stage at #BSRA2024! Don’t miss this fascinating presentation, where he’ll reveal how we’re revolutionizing #ageing research by integrating #Celegans and #AI. What can you expect? 📊 Deep insights into our innovative approach to streamlining ageing studies, utilizing the powerful C. elegans model and cutting-edge AI algorithms. 🌟 EXCLUSIVE PREVIEW! Get a first look at a project we’ve been developing behind the scenes. What better place to show a sneak peak than #BSRA2024? Be prepared for some never-before-seen results! #inwormwetrust British Society for Research on Ageing (BSRA)